{"resourceType":"Bundle","id":"tests-bef27397-e972-46e8-8e92-b8d4fd7985dc-bundle","type":"transaction","entry":[{"resource":{"resourceType":"MeasureReport","id":"90299aeb-5f01-4cad-9015-e5564851f20c","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"2aff8d1d-ddbf-4697-8fcb-5e7b0878d8cf-parameters","parameter":[{"name":"subject","valueString":"bef27397-e972-46e8-8e92-b8d4fd7985dc"}]}],"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/cqf-inputParameters","valueReference":{"reference":"#2aff8d1d-ddbf-4697-8fcb-5e7b0878d8cf-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Inpatient encounter starts in year prior to MP,  ends 1st day of MP. Opioid given twice and antagonist given w/in 24 hrs of each. Two qualifying numerators, but should only count one. One numerator passes."}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/CMS819FHIRHHORAE","period":{"start":"2026-01-01","end":"2026-12-31"},"group":[{"id":"Group_1","population":[{"id":"InitialPopulation_1","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"id":"Denominator_1","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"id":"Numerator_1","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":1}],"measureScore":{"value":0.0}}],"evaluatedResource":[{"reference":"MedicationAdministration/4007451b-68d7-4836-a373-40daf500ff7c"},{"reference":"MedicationAdministration/d7b7a190-701f-4e68-8b83-95dd9556259a"},{"reference":"MedicationAdministration/0fe46050-aac7-4853-add8-b9dabbe182a9"},{"reference":"MedicationAdministration/5432d3d1-2b08-40d9-8ed6-43e1a8a86012"},{"reference":"MedicationAdministration/44e1a56a-d607-4304-aeb2-db9979617eb1"},{"reference":"MedicationAdministration/636b6cda-159a-46ce-8720-89fb98a0b933"},{"reference":"Encounter/72bea60d-fc74-41c3-8697-b57c1843ed67"},{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"}]},"request":{"method":"PUT","url":"MeasureReport/90299aeb-5f01-4cad-9015-e5564851f20c"}},{"resource":{"resourceType":"Bundle","id":"tests-NUMERPass-TwoNumEventsCountOnly1-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/MedicationAdministration/4007451b-68d7-4836-a373-40daf500ff7c","resource":{"resourceType":"MedicationAdministration","id":"4007451b-68d7-4836-a373-40daf500ff7c","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659929","display":"Naloxone (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2025-12-31T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/4007451b-68d7-4836-a373-40daf500ff7c"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/d7b7a190-701f-4e68-8b83-95dd9556259a","resource":{"resourceType":"MedicationAdministration","id":"d7b7a190-701f-4e68-8b83-95dd9556259a","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600","display":"Opioids"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectivePeriod":{"start":"2026-01-04T08:00:00.000+00:00","end":"2026-01-04T08:15:00.000+00:00"}},"request":{"method":"PUT","url":"MedicationAdministration/d7b7a190-701f-4e68-8b83-95dd9556259a"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/0fe46050-aac7-4853-add8-b9dabbe182a9","resource":{"resourceType":"MedicationAdministration","id":"0fe46050-aac7-4853-add8-b9dabbe182a9","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2596175","display":"Nalmefene (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2025-12-31T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/0fe46050-aac7-4853-add8-b9dabbe182a9"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/5432d3d1-2b08-40d9-8ed6-43e1a8a86012","resource":{"resourceType":"MedicationAdministration","id":"5432d3d1-2b08-40d9-8ed6-43e1a8a86012","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659929","display":"Naloxone (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2025-12-31T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/5432d3d1-2b08-40d9-8ed6-43e1a8a86012"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/44e1a56a-d607-4304-aeb2-db9979617eb1","resource":{"resourceType":"MedicationAdministration","id":"44e1a56a-d607-4304-aeb2-db9979617eb1","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2592953","display":"Nalmefene (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2026-01-04T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/44e1a56a-d607-4304-aeb2-db9979617eb1"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/636b6cda-159a-46ce-8720-89fb98a0b933","resource":{"resourceType":"MedicationAdministration","id":"636b6cda-159a-46ce-8720-89fb98a0b933","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600","display":"Opioids"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectivePeriod":{"start":"2025-12-31T08:00:00.000+00:00","end":"2025-12-31T08:15:00.000+00:00"}},"request":{"method":"PUT","url":"MedicationAdministration/636b6cda-159a-46ce-8720-89fb98a0b933"}},{"fullUrl":"https://madie.cms.gov/Encounter/72bea60d-fc74-41c3-8697-b57c1843ed67","resource":{"resourceType":"Encounter","id":"72bea60d-fc74-41c3-8697-b57c1843ed67","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter"]},"status":"finished","class":{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","code":"IMP","display":"inpatient encounter"},"type":[{"coding":[{"system":"http://snomed.info/sct","code":"183452005","display":"Inpatient encounter"}]}],"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"period":{"start":"2025-12-30T08:00:00.000+00:00","end":"2026-01-06T00:00:00.000+00:00"}},"request":{"method":"PUT","url":"Encounter/72bea60d-fc74-41c3-8697-b57c1843ed67"}},{"fullUrl":"https://madie.cms.gov/Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc","resource":{"resourceType":"Patient","id":"bef27397-e972-46e8-8e92-b8d4fd7985dc","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2106-3","display":"White"}},{"url":"text","valueString":"White"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino"}},{"url":"text","valueString":"Hispanic or Latino"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-sex","valueCode":"248153007"}],"identifier":[{"system":"http://hospital.smarthealthit.org","value":"999999999"}],"name":[{"family":"Example","given":["Patient"]}],"gender":"female","birthDate":"1956-01-01"},"request":{"method":"PUT","url":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/90299aeb-5f01-4cad-9015-e5564851f20c","resource":{"resourceType":"MeasureReport","id":"90299aeb-5f01-4cad-9015-e5564851f20c","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"2aff8d1d-ddbf-4697-8fcb-5e7b0878d8cf-parameters","parameter":[{"name":"subject","valueString":"bef27397-e972-46e8-8e92-b8d4fd7985dc"}]}],"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/cqf-inputParameters","valueReference":{"reference":"#2aff8d1d-ddbf-4697-8fcb-5e7b0878d8cf-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Inpatient encounter starts in year prior to MP,  ends 1st day of MP. Opioid given twice and antagonist given w/in 24 hrs of each. Two qualifying numerators, but should only count one. One numerator passes."}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/CMS819FHIRHHORAE","period":{"start":"2026-01-01","end":"2026-12-31"},"group":[{"id":"Group_1","population":[{"id":"InitialPopulation_1","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"id":"Denominator_1","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"id":"Numerator_1","code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":1}],"measureScore":{"value":0.0}}],"evaluatedResource":[{"reference":"MedicationAdministration/4007451b-68d7-4836-a373-40daf500ff7c"},{"reference":"MedicationAdministration/d7b7a190-701f-4e68-8b83-95dd9556259a"},{"reference":"MedicationAdministration/0fe46050-aac7-4853-add8-b9dabbe182a9"},{"reference":"MedicationAdministration/5432d3d1-2b08-40d9-8ed6-43e1a8a86012"},{"reference":"MedicationAdministration/44e1a56a-d607-4304-aeb2-db9979617eb1"},{"reference":"MedicationAdministration/636b6cda-159a-46ce-8720-89fb98a0b933"},{"reference":"Encounter/72bea60d-fc74-41c3-8697-b57c1843ed67"},{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"}]},"request":{"method":"PUT","url":"MeasureReport/90299aeb-5f01-4cad-9015-e5564851f20c"}}]},"request":{"method":"PUT","url":"Bundle/tests-NUMERPass-TwoNumEventsCountOnly1-bundle"}},{"resource":{"resourceType":"Patient","id":"bef27397-e972-46e8-8e92-b8d4fd7985dc","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2106-3","display":"White"}},{"url":"text","valueString":"White"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino"}},{"url":"text","valueString":"Hispanic or Latino"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-sex","valueCode":"248153007"}],"identifier":[{"system":"http://hospital.smarthealthit.org","value":"999999999"}],"name":[{"family":"Example","given":["Patient"]}],"gender":"female","birthDate":"1956-01-01"},"request":{"method":"PUT","url":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"}},{"resource":{"resourceType":"MedicationAdministration","id":"636b6cda-159a-46ce-8720-89fb98a0b933","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600","display":"Opioids"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectivePeriod":{"start":"2025-12-31T08:00:00.000+00:00","end":"2025-12-31T08:15:00.000+00:00"}},"request":{"method":"PUT","url":"MedicationAdministration/636b6cda-159a-46ce-8720-89fb98a0b933"}},{"resource":{"resourceType":"MedicationAdministration","id":"5432d3d1-2b08-40d9-8ed6-43e1a8a86012","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659929","display":"Naloxone (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2025-12-31T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/5432d3d1-2b08-40d9-8ed6-43e1a8a86012"}},{"resource":{"resourceType":"MedicationAdministration","id":"4007451b-68d7-4836-a373-40daf500ff7c","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659929","display":"Naloxone (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2025-12-31T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/4007451b-68d7-4836-a373-40daf500ff7c"}},{"resource":{"resourceType":"MedicationAdministration","id":"d7b7a190-701f-4e68-8b83-95dd9556259a","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600","display":"Opioids"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectivePeriod":{"start":"2026-01-04T08:00:00.000+00:00","end":"2026-01-04T08:15:00.000+00:00"}},"request":{"method":"PUT","url":"MedicationAdministration/d7b7a190-701f-4e68-8b83-95dd9556259a"}},{"resource":{"resourceType":"MedicationAdministration","id":"44e1a56a-d607-4304-aeb2-db9979617eb1","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2592953","display":"Nalmefene (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2026-01-04T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/44e1a56a-d607-4304-aeb2-db9979617eb1"}},{"resource":{"resourceType":"MedicationAdministration","id":"0fe46050-aac7-4853-add8-b9dabbe182a9","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"2596175","display":"Nalmefene (opioid antagonist)"}]},"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"effectiveDateTime":"2025-12-31T09:00:00.000+00:00","dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Intravenous"}]}}},"request":{"method":"PUT","url":"MedicationAdministration/0fe46050-aac7-4853-add8-b9dabbe182a9"}},{"resource":{"resourceType":"Encounter","id":"72bea60d-fc74-41c3-8697-b57c1843ed67","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter"]},"status":"finished","class":{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","code":"IMP","display":"inpatient encounter"},"type":[{"coding":[{"system":"http://snomed.info/sct","code":"183452005","display":"Inpatient encounter"}]}],"subject":{"reference":"Patient/bef27397-e972-46e8-8e92-b8d4fd7985dc"},"period":{"start":"2025-12-30T08:00:00.000+00:00","end":"2026-01-06T00:00:00.000+00:00"}},"request":{"method":"PUT","url":"Encounter/72bea60d-fc74-41c3-8697-b57c1843ed67"}}]}